Clinical Trial: A Study of Skipping Radiation Therapy in People With Breast Cancer

U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07895511) titled 'A Study of Skipping Radiation Therapy in People With Breast Cancer' on Oct. 19.

Brief Summary: The purpose of this study is to find out whether it is safe to skip (omit) radiation therapy to the breast after lumpectomy in people with low-risk HER2-positive breast cancer who are receiving HER2-targeted therapy.

Study Start Date: Oct. 16

Study Type: INTERVENTIONAL

Condition: HER2-positive Breast Cancer Breast Cancer

Intervention: DRUG: HER2-targeted therapy

Participants will continue to receive standard HER2-targeted therapy as part of their usual care

DRUG: Tamoxifen

If participants' cancer is hormone receptor-positive, part...